Brian VanScoy

7PUBLICATIONS
9CO-AUTHORS
Biomolecular modelling and designMedical infection agents (incl. prions)Clinical microbiologyRehabilitation engineeringHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2024
<i>In vivo</i> pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model.

Alexander J Lepak, Brian VanScoy, Chris Rubino

|Mar 22, 2023
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.

Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota

|Mar 22, 2023
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.

A J Lepak, M Trang, J P Hammel

|Feb 09, 2023
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber <i>In Vitro</i> Infection Model.

B D VanScoy, S Jones, H Conde

|Sep 20, 2021
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber <i>In Vitro</i> Infection Model Systems.

Brian D VanScoy, Elizabeth A Lakota, Haley Conde

|Jul 15, 2020
Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber <i>In Vitro</i> Infection Model.

Brian D VanScoy, Nicole E Scangarella-Oman, Steven Fikes

Pageof 2

Frequent Collaborators

6 joint publications

Sujata M Bhavnani

5 joint publications

Paul G Ambrose

2 joint publications

Michael Trang

2 joint publications

David R Andes